Intravascular ULTRA sound-guided percutaneous coronary intervention in patients with STEMI: Rationale and design of the ULTRA-STEMI trial

Table 1 Summary of inclusion and exclusion criteria for the ULTRA-STEMI trial

Inclusion criteria	Exclusion criteria
Patients with symptoms of myocardial ischemia for at least 30 minutes	Patients who have received thrombolytic therapy for index STEMI event
ECG changes indicating STEMI	Known intolerance to heparin, aspirin or P2Y12 inhibitor therapy (clopidogrel, prasugrel, or ticagrelor)
Minimum reference vessel diameter > 2.5 mm	Cardiogenic shock
	Graft vessel as the culprit vessel
Written informed consent	Presentation ≥ 12 hours after symptom onset